Cargando…
Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG
Introduction: The AbC-19™ lateral flow immunoassay (LFIA) performance was evaluated on plasma samples from a SARS-CoV-2 vaccination cohort, WHO international standards for anti-SARS-CoV-2 IgG (human), individuals ≥2 weeks from infection of RT-PCR confirmed SARS-CoV-2 genetic variants, as well as mic...
Autores principales: | Moore, J.S., Robertson, L.J., Price, R., Curry, G., Farnan, J., Black, A., Nesbit, M.A., McLaughlin, J.A., Moore, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472806/ https://www.ncbi.nlm.nih.gov/pubmed/38013966 http://dx.doi.org/10.1016/j.clicom.2022.09.001 |
Ejemplares similares
-
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study
por: Robertson, Louise J., et al.
Publicado: (2022) -
IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS
por: Hartwig, Jelka, et al.
Publicado: (2020) -
Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months
por: Robertson, Louise J, et al.
Publicado: (2021) -
User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test
por: Jing, Min, et al.
Publicado: (2022) -
User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
por: Jing, Min, et al.
Publicado: (2021)